BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34803670)

  • 21. XPC silencing sensitizes glioma cells to arsenic trioxide via increased oxidative damage.
    Liu SY; Wen CY; Lee YJ; Lee TC
    Toxicol Sci; 2010 Jul; 116(1):183-93. PubMed ID: 20403967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
    López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
    BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation between expression of long non-coding RNA ZXF1 and prognosis of lung adenocarcinoma and its potential molecular mechanism].
    Pan GF; Zhou XF; Zhao JP
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):102-108. PubMed ID: 28219204
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis.
    Zhao M; Chen Z; Zheng Y; Liang J; Hu Z; Bian Y; Jiang T; Li M; Zhan C; Feng M; Wang Q
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1463-1472. PubMed ID: 32221746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma.
    Zhao M; Zhang Y; Zhang H; Wang S; Zhang M; Chen X; Wang H; Zeng G; Chen X; Liu G; Zhou C
    Lung Cancer; 2015 Feb; 87(2):98-106. PubMed ID: 25512094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation.
    Zhang Y; Yu JJ; Tian Y; Li ZZ; Zhang CY; Zhang SF; Cao LQ; Zhang Y; Qian CY; Zhang W; Zhou HH; Yin JY; Liu ZQ
    Oncotarget; 2015 Sep; 6(28):25441-51. PubMed ID: 26213845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of HIF-2α and its anti-radiotherapy effect in lung cancer stem cells.
    Sun JC; He F; Yi W; Wan MH; Li R; Wei X; Wu R; Niu DL
    Genet Mol Res; 2015 Dec; 14(4):18110-20. PubMed ID: 26782458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gli1 regulates stemness characteristics in gastric adenocarcinoma.
    Qi W; Yang Z; Feng Y; Li H; Che N; Liu L; Xuan Y
    Diagn Pathol; 2020 May; 15(1):60. PubMed ID: 32430068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study.
    He A; Qi W; Huang Y; Feng T; Chen J; Sun Y; Shen Z; Yao Y
    Exp Ther Med; 2012 Sep; 4(3):435-441. PubMed ID: 23181114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy.
    Zhang R; Jia M; Xue H; Xu Y; Wang M; Zhu M; Sun M; Chang J; Wei Q
    Sci Rep; 2017 Sep; 7(1):10702. PubMed ID: 28878296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XPC as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis.
    Malik SS; Zia A; Rashid S; Mubarik S; Masood N; Hussain M; Yasmin A; Bano R
    Breast Cancer; 2020 Nov; 27(6):1168-1176. PubMed ID: 32562189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuated XPC expression is not associated with impaired DNA repair in bladder cancer.
    Naipal KA; Raams A; Bruens ST; Brandsma I; Verkaik NS; Jaspers NG; Hoeijmakers JH; van Leenders GJ; Pothof J; Kanaar R; Boormans J; van Gent DC
    PLoS One; 2015; 10(4):e0126029. PubMed ID: 25927440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xeroderma pigmentosum complementation group C protein (XPC) expression in basal cell carcinoma.
    Yang LC; Hsiao YP; Lu CT; Huang CH; Chao WR; Lin YT; Su HA; Chang SL; Chung JG
    In Vivo; 2015; 29(1):35-8. PubMed ID: 25600527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. XPC beyond nucleotide excision repair and skin cancers.
    Zebian A; Shaito A; Mazurier F; Rezvani HR; Zibara K
    Mutat Res Rev Mutat Res; 2019; 782():108286. PubMed ID: 31843141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
    Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
    Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of XPC: implications in cancer and oxidative DNA damage.
    Melis JP; Luijten M; Mullenders LH; van Steeg H
    Mutat Res; 2011; 728(3):107-17. PubMed ID: 21763452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xeroderma pigmentosum complementation group C protein (XPC) serves as a general sensor of damaged DNA.
    Shell SM; Hawkins EK; Tsai MS; Hlaing AS; Rizzo CJ; Chazin WJ
    DNA Repair (Amst); 2013 Nov; 12(11):947-53. PubMed ID: 24051049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of decreased GRK6 expression in lung adenocarcinoma.
    Yao S; Zhong L; Liu J; Feng J; Bian T; Zhang Q; Chen J; Lv X; Chen J; Liu Y
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2541-2549. PubMed ID: 27601164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.